Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.490
-0.060 (-3.87%)
Apr 1, 2025, 4:00 PM EDT - Market closed

BDTX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-69.68-82.44-91.17-125.6-67.25
Upgrade
Depreciation & Amortization
0.340.440.510.210.05
Upgrade
Loss (Gain) From Sale of Assets
-0.090.36-2.230-
Upgrade
Loss (Gain) From Sale of Investments
-3.78-1.170.542.181.7
Upgrade
Loss (Gain) on Equity Investments
--2.25--
Upgrade
Stock-Based Compensation
10.639.612.214.047.77
Upgrade
Other Operating Activities
2.972.812.732.010.55
Upgrade
Change in Accounts Payable
1.680.6-2.231.571.07
Upgrade
Change in Other Net Operating Assets
-4.383.09-7.675.453.97
Upgrade
Operating Cash Flow
-62.3-66.72-85.08-100.15-52.15
Upgrade
Capital Expenditures
--0.03-0.19-2.71-0.14
Upgrade
Sale of Property, Plant & Equipment
0.090.10.01--
Upgrade
Investment in Securities
16.8716.2853.55133.32-281.55
Upgrade
Investing Cash Flow
16.9716.3553.37130.61-281.69
Upgrade
Issuance of Common Stock
25.5571.930.180.73216.22
Upgrade
Other Financing Activities
-----1.28
Upgrade
Financing Cash Flow
25.5571.930.180.73214.94
Upgrade
Net Cash Flow
-19.7921.56-31.5431.19-118.89
Upgrade
Free Cash Flow
-62.3-66.75-85.27-102.86-52.29
Upgrade
Free Cash Flow Per Share
-1.13-1.52-2.35-2.84-1.59
Upgrade
Levered Free Cash Flow
-35.76-37.65-55.39-59.04-30.94
Upgrade
Unlevered Free Cash Flow
-35.76-37.65-55.39-59.04-30.94
Upgrade
Change in Net Working Capital
-0.67-6.389.88-8.72-4.87
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q